bioMérieux South Africa Pty

http://www.biomerieux.com

A world leader in the field of in vitro diagnostics for over 45 years, bioMérieux is present in more than 150 countries through 39 subsidiaries and a large network of distributors. In 2008, revenues reached €1.111 billion with 84% of sales outside of France. bioMérieux provides diagnostic solutions (reagents, instruments, software) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Our products are used for diagnosing infectious diseases and providing high medical value results for cancer screening and monitoring and cardiovascular emergencies. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. bioMérieux is listed on the NYSE Euronext Paris market (Symbol: BIM - ISIN: FR0010096479). Other information can be found at www.biomerieux.com. *

	Start	2007-12-13 established
	Industry	diagnostics (medical/biological)
	Industry 2	in vitro diagnostics (IVD)

	Region	South Africa_oo
	Country	South Africa
	Street	7 Malibongwe Drive
	City	2125 Randburg
		Address record changed: 2010-05-09

Basic data	Employees	n. a.

		* Document for »About Section«: bioMérieux S.A.. (1/7/10). "Press Release: Philips and bioMérieux Announce Partnership to Develop and Market Next-generation Handheld Diagnostic Solutions for Point-of-Care". Amsterdam & Marcy l’Etoile.

		Record changed: 2011-11-27

To subscribe to our free, monthly [MSC] Newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

NEW: Visit our brand new forthcoming web portals Life-Sciences-Germany.com and Life-Sciences-Europe.com

» top

Follow Us!

Top News

Upcoming Events

Associations

Partners

bioMérieux South Africa Pty